Reprint of: New guidelines for stage III melanoma (the French Cutaneous Oncology Group)

Affiliation auteurs!!!! Error affiliation !!!!
TitreReprint of: New guidelines for stage III melanoma (the French Cutaneous Oncology Group)
Type de publicationJournal Article
Year of Publication2019
AuteursGuillot B., Dupuy A., Pracht M., Jeudy G., Hindie E., Desmedt E., Jouary T., Leccia M-T
JournalBULLETIN DU CANCER
Volume106
Pagination560-573
Date PublishedJUN
Type of ArticleArticle
ISSN0007-4551
Mots-clésguidelines, Immunotherapy, sentinel node, Stage III melanoma, Targeted therapy
Résumé

Improved knowledge of sentinel node procedures coupled with the results of adjuvant clinical trials in stage III melanoma have prompted the French Cutaneous Oncology Group to propose new guidelines for the management of stage III melanoma. These guidelines comply with the principles of the evidence-based medicine.

DOI10.1016/j.bulcan.2019.04.001